Seeking to cure the incurable - Canada and Japan setting the world pace for innovations in regenerative medicine
National Post article highlights the important role the Centre for Commercialization of Regenerative Medicine (CCRM) is taking to help Canadian cell therapy companies like RepliCel Life Sciences (TSX.V: RP) create pathways for commercialization in Canada and Japan.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet – the regenerative medicine network
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.